IDM Pharma, Inc. (IDMI) Reports 2007 Financial Data
IDM Pharma, Inc. (Nasdaq: IDMI) today reported financial results for the fourth quarter and full year ended December 31, 2007. The financial information represents both the results from IDM Pharma, Inc. and its subsidiary, IDM Pharma S.A. Total revenues for the year ended December 31, 2007 were $14.6 million, with a net loss of $18.3 million. Cash on hand was $28.4 million; up from 2006 which was $10.2 million but lower from the $33.2 million reported on September 30, 2007. The company states they believe that their existing cash resources are sufficient to meet their cash requirements until the first…